Skip to content

Effectiveness of a mouthwash and toothpaste containing PHTALOX in controlling symptoms of COVID-19 and flu

Efficacy of mouthwash and toothpaste containing PHTALOX in the clinical control of COVID-19 and Flu Syndrome: a randomized triple-blind clinical tria

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-8x8g36
Enrollment
Unknown
Registered
2020-10-29
Start date
2020-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, Human Influenza

Interventions

The project has two groups, namely: a) Experimental group (n = 250): each participant will receive a Kit for oral care containing toothbrush and dental floss + mouthwash and dental gel containing PHTA
Other
B97.2
D018352

Sponsors

Instituto Federal do Paraná
Lead Sponsor
Instituto Federal do Paraná
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adult individuals (> 18 years old), of both sexes, from the city of Londrina with clinical suspicion of COVID-19, submitted to testing through RT-PCR at the Sabará-Londrina Emergency Care Unit (UPA), who have no contraindications to perform mouthwash / gargle and have access to the cell phone with communication application (WhatsApp).

Exclusion criteria

Exclusion criteria: Patients who do not present clinical conditions, during the research, to perform mouthwashes / gargles daily, who did not tolerate the use of the products, who are hospitalized for treatment of the disease or give up participating in the research.

Design outcomes

Primary

MeasureTime frame
Improvement of clinical symptoms in the period of 14 days, verified through the self-administered questionnaire with a reduction of at least 30% of respiratory symptoms.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactMarcelo Poleti

Instituto Federal do Paraná

marcelo_poleti@yahoo.com.br+55-43-38786101

Outcome results

None listed

Source: REBEC (via WHO ICTRP)